Evidence map›Paper›PMID 39533994›Full record

ArticleAsian journal of urology2024

LncRNA

Yaru Zhu, Zhijing Wang, Haopeng Li, Zhen Ren, Tong Zi, Xin Qin, Wenhuizi Sun, Xi Chen, Gang Wu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Asian journal of urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yaru ZhuDepartment of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Zhijing WangDepartment of Gastroenterology and Hepatology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Haopeng LiDepartment of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Zhen RenDepartment of Medicine, Dalian University of Technology, Dalian, China.
Tong ZiDepartment of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Xin QinDepartment of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Wenhuizi SunDepartment of Obstetrics and Gynecology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Xi ChenDepartment of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Gang WuDepartment of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Long non-coding RNAs (lncRNAs) play an important role in tumor progression. Numerous studies show that lncRNAs are strongly associated with prostate cancer (PCa) progression. The aim of this study was to investigate the pathway through which lncRNA Methods: We compared Results: Conclusion: Our

Indexed as

GlycolysisHexokinase-2Long non-coding RNAMicroRNAProstate cancerWarburg effect

Identifiers

PMID39533994
PMCPMC11551385

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.